vs
NN INC（NNBR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
NN INC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$104.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-3.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -7.0%）
NN集团是NN投资伙伴与荷兰国家保险的母公司，旗下荷兰国家保险是荷兰规模最大的保险与资产管理机构之一。集团总部设于荷兰海牙，鹿特丹办事处坐落于代尔夫特门大厦，该大厦2009年之前一直是荷兰最高摩天楼，除此之外集团在荷兰埃德也设有办事处。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
NNBR vs PBYI — 直观对比
营收规模更大
NNBR
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出29.4%
-1.7%
自由现金流更多
PBYI
多$17.7M
$-3.3M
两年增速更快
PBYI
近两年复合增速
-7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.7M | $75.5M |
| 净利润 | $-12.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -9.9% | 22.7% |
| 净利率 | -12.0% | — |
| 营收同比 | -1.7% | 27.7% |
| 净利润同比 | 40.2% | — |
| 每股收益（稀释后） | $-0.35 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NNBRPBYI
| Q4 25 | $104.7M | $75.5M | ||
| Q3 25 | $103.9M | $54.5M | ||
| Q2 25 | $107.9M | $52.4M | ||
| Q1 25 | $105.7M | $46.0M | ||
| Q4 24 | $106.5M | $59.1M | ||
| Q3 24 | $113.6M | $80.5M | ||
| Q2 24 | $123.0M | $47.1M | ||
| Q1 24 | $121.2M | $43.8M |
净利润NNBRPBYI
| Q4 25 | $-12.5M | — | ||
| Q3 25 | $-6.7M | $8.8M | ||
| Q2 25 | $-8.1M | $5.9M | ||
| Q1 25 | $-6.7M | $3.0M | ||
| Q4 24 | $-21.0M | — | ||
| Q3 24 | $-2.6M | $20.3M | ||
| Q2 24 | $-2.2M | $-4.5M | ||
| Q1 24 | $-12.5M | $-4.8M |
毛利率NNBRPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率NNBRPBYI
| Q4 25 | -9.9% | 22.7% | ||
| Q3 25 | -2.2% | 17.6% | ||
| Q2 25 | -1.4% | 12.7% | ||
| Q1 25 | -4.5% | 8.7% | ||
| Q4 24 | -15.8% | 22.6% | ||
| Q3 24 | -3.3% | 27.4% | ||
| Q2 24 | -1.7% | -4.6% | ||
| Q1 24 | -3.9% | -5.3% |
净利率NNBRPBYI
| Q4 25 | -12.0% | — | ||
| Q3 25 | -6.4% | 16.2% | ||
| Q2 25 | -7.5% | 11.2% | ||
| Q1 25 | -6.3% | 6.5% | ||
| Q4 24 | -19.7% | — | ||
| Q3 24 | -2.3% | 25.2% | ||
| Q2 24 | -1.8% | -9.6% | ||
| Q1 24 | -10.3% | -11.0% |
每股收益（稀释后）NNBRPBYI
| Q4 25 | $-0.35 | $0.26 | ||
| Q3 25 | $-0.23 | $0.17 | ||
| Q2 25 | $-0.26 | $0.12 | ||
| Q1 25 | $-0.23 | $0.06 | ||
| Q4 24 | $-0.52 | $0.40 | ||
| Q3 24 | $-0.13 | $0.41 | ||
| Q2 24 | $-0.12 | $-0.09 | ||
| Q1 24 | $-0.34 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $34.0M | $130.3M |
| 总资产 | $440.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资NNBRPBYI
| Q4 25 | $11.4M | $97.5M | ||
| Q3 25 | $12.2M | $94.4M | ||
| Q2 25 | $9.5M | $96.0M | ||
| Q1 25 | $11.7M | $93.2M | ||
| Q4 24 | $18.1M | $101.0M | ||
| Q3 24 | $12.4M | $96.7M | ||
| Q2 24 | $13.7M | $96.8M | ||
| Q1 24 | $20.6M | $107.2M |
总债务NNBRPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益NNBRPBYI
| Q4 25 | $34.0M | $130.3M | ||
| Q3 25 | $49.6M | $115.3M | ||
| Q2 25 | $59.5M | $104.7M | ||
| Q1 25 | $67.3M | $97.1M | ||
| Q4 24 | $74.5M | $92.1M | ||
| Q3 24 | $106.6M | $71.1M | ||
| Q2 24 | $108.4M | $48.5M | ||
| Q1 24 | $116.1M | $51.0M |
总资产NNBRPBYI
| Q4 25 | $440.8M | $216.3M | ||
| Q3 25 | $451.0M | $202.9M | ||
| Q2 25 | $460.8M | $194.9M | ||
| Q1 25 | $460.7M | $196.2M | ||
| Q4 24 | $456.9M | $213.3M | ||
| Q3 24 | $483.1M | $220.7M | ||
| Q2 24 | $497.2M | $205.0M | ||
| Q1 24 | $512.8M | $214.1M |
负债/权益比NNBRPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-3.3M | $14.4M |
| 自由现金流率自由现金流/营收 | -3.2% | 19.1% |
| 资本支出强度资本支出/营收 | 1.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-7.2M | $41.7M |
8季度趋势，按日历期对齐
经营现金流NNBRPBYI
| Q4 25 | $-1.5M | $14.4M | ||
| Q3 25 | $11.2M | $9.7M | ||
| Q2 25 | $-696.0K | $14.1M | ||
| Q1 25 | $-3.3M | $3.6M | ||
| Q4 24 | $6.7M | $15.6M | ||
| Q3 24 | $5.0M | $11.0M | ||
| Q2 24 | $-1.3M | $1.0M | ||
| Q1 24 | $712.0K | $11.2M |
自由现金流NNBRPBYI
| Q4 25 | $-3.3M | $14.4M | ||
| Q3 25 | $7.7M | $9.7M | ||
| Q2 25 | $-4.4M | $14.1M | ||
| Q1 25 | $-7.3M | $3.6M | ||
| Q4 24 | $3.7M | $15.6M | ||
| Q3 24 | $-1.3M | $11.0M | ||
| Q2 24 | $-4.9M | $1.0M | ||
| Q1 24 | $-4.7M | — |
自由现金流率NNBRPBYI
| Q4 25 | -3.2% | 19.1% | ||
| Q3 25 | 7.4% | 17.7% | ||
| Q2 25 | -4.1% | 26.8% | ||
| Q1 25 | -6.9% | 7.7% | ||
| Q4 24 | 3.5% | 26.4% | ||
| Q3 24 | -1.2% | 13.7% | ||
| Q2 24 | -4.0% | 2.1% | ||
| Q1 24 | -3.9% | — |
资本支出强度NNBRPBYI
| Q4 25 | 1.8% | 0.0% | ||
| Q3 25 | 3.3% | 0.0% | ||
| Q2 25 | 3.4% | 0.0% | ||
| Q1 25 | 3.7% | 0.1% | ||
| Q4 24 | 2.8% | 0.0% | ||
| Q3 24 | 5.5% | 0.0% | ||
| Q2 24 | 2.9% | 0.0% | ||
| Q1 24 | 4.5% | 0.0% |
现金转化率NNBRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NNBR
| Automotive | $53.1M | 51% |
| Power Solutions | $45.5M | 43% |
| Other End Market | $4.7M | 4% |
PBYI
暂无分部数据
